Interestingly, in the presence of TGF-β1, YY1 loss increased Smad2 phosphorylation, indicating that melanoma cells display enhanced sensitivity to TGF-β1 when YY1 levels are low (Figure 3A). The gene discussed is SMAD2; the disease is melanoma.